
Overview
Tony G. Farah, MD, is executive vice president, and chief medical and clinical transformation officer for Highmark Health. He was selected by Modern Healthcare magazine as one of the country's 50 Most Influential Clinical Executives in 2019. A renowned cardiologist, Dr. Farah also serves on Highmark Health's leadership team and led a value-based clinical transformation initiative for Highmark Health designed to save health care costs while optimizing members' and patients' health at every stage of the clinical care journey. Dr. Farah’s clinical work, research, training, and mentoring alone qualify him as someone who has profoundly improved his corner of health care. He has taken on increasingly far-reaching clinician-leader roles. He also earned a place on Becker’s Hospital Review “CMOs to Know” list. He has extensive experience in clinical research and is widely published in medical journals. Dr. Farah earned his medical degree from the American University of Beirut School of Medicine in Beirut, Lebanon. He completed both a residency and a fellowship in cardiology at Allegheny General Hospital in Pittsburgh, Pennsylvania. He is certified by the American Board of Internal Medicine in interventional cardiology and cardiovascular disease. He speaks English.
His clinical expertise encompasses Atherosclerosis.
Dr. Farah is board certified in American Board Of Internal Medicine - Cardiovascular Disease. He is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 2 clinical trials. Dr. Farah is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- HMO
- POS
- PPO
Locations
12311 Perry Highway, Wexford, PA 15090
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
2 Clinical Trials
AHN Cancer Institute-Med Onc & Infusions At Allegheny General Hospital
Nathan Bahary MD, PhD received his B.A. from Cornell University, an M.D. from the Cornell University School of Medicine, and his Ph.D. from the Rockefeller University. He completed his residency at Beth Israel Hospital in Boston. He did his postgraduate training at the Dana Farber Cancer Institute, Harvard, and Brigham and Women’s Hospital system before joining the faculty of UPMC as the Director of the Pancreatic Cancer Center. Since 2021, he is the Division Chief of Medical Oncology at AHN Cancer Institute and Director of AHNCI Clnical Research. Amongst his various appointments Dr. Bahary is a member of the NCI Pancreatic Task Force, the Eastern Cooperative Oncology Group (ECOG) where he serves on the ECOG GI Steering Committee and the American Society of Clinical Oncology (ASCO) His basic research interests lie in the intersection between gastrointestinal development, metabolic stress pathways, immunology, and cancer. He has a broad research background in cancer genetics, developmental biology, molecular biology, and clinical investigations, with specific training and expertise in key research areas broadly within the field of gastrointestinal oncology, and specifically within pancreatic cancer. Building on his work at Harvard Medical School, Dr. Bahary is using insights gained by studying vertebrate development to determine how cancers grow. Clinical trials emanating from this research will continue at AHN Cancer Institute and are expected to lead to the development of new targeted agents and immunologic strategies for treating cancer. Dr. Bahary is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Bahary is board certified in Medical Oncology, American Board Of Internal Medicine.
University Of Pittsburgh Physicians, Department Of Women's Health
Robert P. Edwards, MD, is the Chair of Ob/Gyn/RS at UPMC Magee-Womens Hospital. Dr. Edwards is co-leader of the UPMC Gynecologic Cancer Program, and a professor of medicine in the Department of Obstetrics, Gynecology, and Reproductive Sciences at the University of Pittsburgh School of Medicine.Dr. Edwards specializes in all aspects of gynecologic oncology, and has a particular interest in intraperitoneal chemotherapy. and immunotherapty.Dr. Edwards is board-certified in obstetrics and gynecology, as well as gynecologic oncology. He received an undergraduate degree at Gettysburg College in Gettysburg, Pa., and received a medical degree at the University of Pittsburgh School of Medicine. Dr. Edwards completed a residency in obstetrics and gynecology at Magee-Womens Hospital of UPMC, and a fellowship in gynecologic oncology at the University of Alabama at Birmingham.Dr. Edwards is a member of professional organizations including the University of Pittsburgh Physicians Board of Directors, American Medical Association, American College of Surgeons, American College of Obstetricians and Gynecologists, American Association for Cancer Research, American Society of Clinical Oncology, Society of Gynecologic Oncologists, American Society of Colposcopy and Cervical Pathology, International Society for Biological Therapy of Cancer, American Association for the Advancement of Science, and the International Gynecologic Cancer Society. Dr. Edwards is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Endometrial Cancer, Vaginal Cancer, Vulvectomy, and Endoscopy. Dr. Edwards is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Edwards is currently accepting new patients.
Office
Leonard Appleman is an Oncologist practicing medicine in Pittsburgh, Pennsylvania. Dr. Appleman is highly rated in 23 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Familial Prostate Cancer, WT1-Related Wilms Tumor Syndromes, and Nephrectomy.
Frequently Asked Questions about Dr. Tony G. Farah
How do I make an appointment with Dr. Tony G. Farah?
You can book an appointment with Dr. Tony G. Farah by calling their office at 878-332-4214. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Tony G. Farah a top-rated expert for Atherosclerosis?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Tony G. Farah is classified as an Experienced expert for Atherosclerosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Tony G. Farah specialize in?
While Dr. Tony G. Farah is a Cardiology, they have specific expertise in Atherosclerosis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Cardiology.
Does Dr. Tony G. Farah participate in research or clinical trials?
Yes. Dr. Tony G. Farah has published 4 articles and abstracts on conditions like Atherosclerosis. You can view a list of Dr. Tony G. Farah's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Tony G. Farah accept my insurance?
Dr. Tony G. Farah accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 878-332-4214 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers

